PetMed Express, Inc. (PETS)
NASDAQ: PETS · IEX Real-Time Price · USD
4.020
-0.020 (-0.50%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Company Description

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.

The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.

It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards.

The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PetMed Express, Inc.
PetMed Express logo
Country United States
Founded 1996
Industry Pharmaceutical Retailers
Sector Healthcare
Employees 287
CEO Ms. Sandra Y. Campos

Contact Details

Address:
420 South Congress Avenue
Delray Beach, Florida 33445
United States
Phone (561) 426-4444
Website 1800petmeds.com

Stock Details

Ticker Symbol PETS
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001040130
CUSIP Number 716382106
ISIN Number US7163821066
Employer ID 65-0680967
SIC Code 5912

Key Executives

Name Position
Mathew N. Hulett Chief Executive Officer, President and Director
Christine Chambers Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer, Treasurer and Secretary
Mark Moseley Chief Technology and Information Officer
Daniel Job Pingree Chief Marketing Officer
Jacqueline Smith Vice President of People
Wendy Zalai Corporate Controller and Corporate Secretary

Latest SEC Filings

Date Type Title
Jul 2, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jun 24, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jun 24, 2024 DEF 14A Other definitive proxy statements
Jun 24, 2024 8-K Current Report
Jun 14, 2024 10-K Annual Report
Jun 11, 2024 8-K Current Report
May 31, 2024 8-K Current Report
May 20, 2024 8-K Current Report
Apr 29, 2024 8-K Current Report
Apr 15, 2024 8-K Current Report